Ayiziba·Tuerhong ,YANG Jianhua,WANG Xiaomei,et al.Effects and mechanism of Hugan buzure formula on intrahepatic cholestatic liver injury in rats[J].ZHONGGUO YAOFANG,2023,34(16):1943-1948.
Ayiziba·Tuerhong ,YANG Jianhua,WANG Xiaomei,et al.Effects and mechanism of Hugan buzure formula on intrahepatic cholestatic liver injury in rats[J].ZHONGGUO YAOFANG,2023,34(16):1943-1948. DOI: 10.6039/j.issn.1001-0408.2023.16.05.
Effects and mechanism of Hugan buzure formula on intrahepatic cholestatic liver injury in rats
To study the effects of Hugan buzure formula (HBF) on intrahepatic cholestatic liver injury in rats and its potential mechanism.
METHODS
2
Rats were randomly divided into control group, model group, ursodeoxycholic acid (UDCA) group (positive control, 60 mg/kg ) and HBF low-dose, middle-dose and high-dose groups (HBF-L, HBF-M, HBF-H groups, 0.4, 0.8, 1.6 g/kg ), with 6 rats in each group. The rats in each drug group were given the corresponding drug solution intragastrically, once a day, for 7 consecutive days. The rats in the control group and the model group were given equal volumes of water intragastrically. On the 5th day, except for the control group, the rats in other groups were single intragastrically administered with alpha-naphthyl isothiocyanate olive oil solution (100 mg/kg) to establish the model. After 48 h of modeling, the contents of liver function indexes (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total bile acid, total bilirubin, direct bilirubin) and oxidative stress indexes [malondialdehyde (MDA), glutathione (GSH), superoxide dismutase] in serum of rats were detected; the pathological changes of liver tissue were observed. The mRNA expressions of inflammation-related factors [tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β)]
and farnesoid X receptor (FXR) signaling pathway-related factors [FXR, small heterodimer partner (SHP), multidrug resistance protein 2 (MRP2), bile salt export pump (BSEP), Na
+
-taurocholate cotransporting polypeptide (NTCP), organic anion-transporting polypeptide 2 (OATP2) and cholesterol 7α-hydroxylase (CYP7A1)], the expressions of FXR signaling pathway-related proteins (FXR, MRP2, BSEP, NTCP) and nuclear factor-κB p65 (NF-κB p65) in liver tissue were detected.
RESULTS
2
Compared with the model group, the contents of liver function indexes and the level of MDA in serum, the mRNA expressions of the above inflammation-related factors and CYP7A1, and the relative expression of NF-κB p65 in liver tissue were significantly decreased; the levels of GSH in serum, the mRNA expressions of FXR, SHP, MRP2, BSEP, NTCP and OATP2, and the relative expressions of FXR, MRP2, BSEP and NTCP in liver tissue were significantly increased (
P
<0.05 or
P
<0.01); the pathological changes of liver tissue were significantly improved. Only some indexes in HBF-L group, HBF-M group and UDCA group were significantly reversed (
P
<0.05 or
P
<0.01).
CONCLUSIONS
2
HBF can prevent intrahepatic cholestatic liver injury in rats, and the effects may be related to the activation of FXR signaling pathway and the reduction of inflammation and oxidative stress.
关键词
护肝布祖热方肝内胆汁淤积性肝损伤法尼酯X受体信号通路炎症反应氧化应激
Keywords
intrahepatic cholestatic liver injuryfarnesoid X receptor signaling pathwayinflammatory reactionoxidative stress
references
ZOU M Z,WANG A Z,WEI J J,et al. An insight into the mechanism and molecular basis of dysfunctional immune response involved in cholestasis[J]. Int Immunopharmacol,2021,92:107328.
ZHANG R J,HUANG T,ZHANG Q Y,et al. Xiaoyan Lidan formula ameliorates α-naphthylisothiocyanate-in-duced intrahepatic cholestatic liver injury in rats as revealed by non-targeted and targeted metabolomics[J]. J Pharm Biomed Anal,2020,179:112966.
NIETSCHE T R,DOTTA G,BARCAUI C B,et al. Cholestatic pruritus:a knowledge update[J]. An Bras Dermatol,2022,97(3):332-337.
MENG F C,ZONG W,WEI X D,et al. Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid X receptor-mediated bile acid metabolism[J]. Phytomedicine,2021,87:153588.
WANG C,PENG F,ZHONG B H,et al. Metabolomic analysis reveals the therapeutic effects of MBT1805,a novel pan-peroxisome proliferator-activated receptor agonist,on α-naphthylisothiocyanate-induced cholestasis in mice[J]. Front Pharmacol,2021,12:732478.
TELBISZ Á,HOMOLYA L. Recent advances in the exploration of the bile salt export pump(BSEP/ABCB11)function[J]. Expert Opin Ther Targets,2016,20(4):501-514.
YAO H,XU Y W,YIN L H,et al. Dioscin protects ANIT-induced intrahepatic cholestasis through regulating tran-sporters,apoptosis and oxidative stress[J]. Front Pharmacol,2017,8:116.
LI X,LIU R P,YU L X,et al. Alpha-naphthyliso-thiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes[J]. Toxicology,2016,370:106-115.
XU L L,SHENG T T,LIU X L,et al. Analyzing the hepatoprotective effect of the Swertia cincta Burkillextract against ANIT-induced cholestasis in rats by modulating the expression of transporters and metabolic enzymes[J]. J Ethnopharmacol,2017,209:91-99.
WEI X D,MA Y X,DONG Z Y,et al. Dehydrodiconiferyl alcohol,a lignan from Herpetospermum pedunculosum,alleviates cholestasis by activating pathways associa-ted with the farnesoid X receptor[J]. Phytomedicine,2021,80:153378.
PANZITT K,ZOLLNER G,MARSCHALL H U,et al. Recent advances on FXR-targeting therapeutics[J]. Mol Cell Endocrinol,2022,552:111678.